Kymera Therapeutics
Developing targeted protein degraders
- B2B
About Kymera Therapeutics
A clinical-stage biotechnology company pioneering targeted protein degradation to develop medicines for immunological diseases and oncology, improving patient outcomes
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Watertown, Massachusetts, United States
- Founded
- 2016
- Revenue
- $39.2MFY2025, publicly reported
- Website
- kymeratx.com
Kymera Therapeutics at a glance
Kymera Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Watertown, Massachusetts, United States.
Kymera Therapeutics was founded in 2016.
Kymera Therapeutics has 251–1,000 employees.
Kymera Therapeutics's revenue is $39.2M (FY2025, publicly reported).
Frequently asked questions about Kymera Therapeutics
What is Kymera Therapeutics's revenue?
Kymera Therapeutics's revenue is $39.2M (FY2025, publicly reported).
How many employees does Kymera Therapeutics have?
Kymera Therapeutics has 251–1,000 employees.
Where is Kymera Therapeutics headquartered?
Kymera Therapeutics is headquartered in Watertown, Massachusetts, United States.
Selling to companies like Kymera Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies